Market Chatter: Humana Exploring Pharmacy Partnership With Mark Cuban

MT Newswires Live12-05 04:41

Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.

Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.

Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.

Shares of Humana were down 2.14% in recent Thursday trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 251.99, Change: -4.93, Percent Change: -1.92

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589121832?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-05 04:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589121832","market":"us","top_or_hot":-1,"title":"Market Chatter: Humana Exploring Pharmacy Partnership With Mark Cuban","media":"MT Newswires Live","content":"<html><body><p> Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.</p><p>Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.</p><p>Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.</p><p>Shares of Humana were down 2.14% in recent Thursday trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p><p>Price: 251.99, Change: -4.93, Percent Change: -1.92</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: Humana Exploring Pharmacy Partnership With Mark Cuban</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: Humana Exploring Pharmacy Partnership With Mark Cuban\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-05 04:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.</p><p>Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.</p><p>Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.</p><p>Shares of Humana were down 2.14% in recent Thursday trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p><p>Price: 251.99, Change: -4.93, Percent Change: -1.92</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HUM","symbol_name":"哈门那","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589121832","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589121832","pubTimestamp":1764880896,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Humana  is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.Shares of Humana were down 2.14% in recent Thursday trading.Price: 251.99, Change: -4.93, Percent Change: -1.92","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HUM":"哈门那","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","HUM.AU":"HUMM GROUP LTD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4585":"ETF&股票定投概念","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK7500":"支付概念","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4566":"资本集团","BK7093":"消费信贷","BK4588":"碎股","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","BK4154":"管理型保健护理","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC"},"translate_title":"市场热议：Humana探索与Mark Cuban建立药房合作伙伴关系","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUM.AU":1,"HUM":1},"content_text":"Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.Shares of Humana were down 2.14% in recent Thursday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 251.99, Change: -4.93, Percent Change: -1.92","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589121832","isCrawlerRequest":true}